Evidence map›Paper›PMID 38184696›Full record

ArticleScientific reports2024

[Formula: see text] model for analyzing [Formula: see text]-19 pandemic process via [Formula: see text]-Caputo fractional derivative and numerical simulation.

Behnam Mohammadaliee, Vahid Roomi, Mohammad Esmael Samei

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Behnam Mohammadaliee *Department of Mathematics, Azarbaijan Shahid Madani University, Tabriz, Iran.
Vahid Roomi *Department of Mathematics, Azarbaijan Shahid Madani University, Tabriz, Iran.
Mohammad Esmael Samei *Department of Mathematics, Faculty of Basic Science, Bu-Ali Sina University, Hamedan, 65178-38695, Iran. mesamei@basu.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to develop the [Formula: see text] epidemic model for [Formula: see text]-[Formula: see text] utilizing the [Formula: see text]-Caputo fractional derivative. The reproduction number ([Formula: see text]) is calculated utilizing the next generation matrix method. The equilibrium points of the model are computed, and both the local and global stability of the disease-free equilibrium point are demonstrated. Sensitivity analysis is discussed to describe the importance of the parameters and to demonstrate the existence of a unique solution for the model by applying a fixed point theorem. Utilizing the fractional Euler procedure, an approximate solution to the model is obtained. To study the transmission dynamics of infection, numerical simulations are conducted by using MatLab. Both numerical methods and simulations can provide valuable insights into the behavior of the system and help in understanding the existence and properties of solutions. By placing the values [Formula: see text], [Formula: see text] and [Formula: see text] instead of [Formula: see text], the derivatives of the Caputo and Caputo-Hadamard and Katugampola appear, respectively, to compare the results of each with real data. Besides, these simulations specifically with different fractional orders to examine the transmission dynamics. At the end, we come to the conclusion that the simulation utilizing Caputo derivative with the order of 0.95 shows the prevalence of the disease better. Our results are new which provide a good contribution to the current research on this field of research.

Identifiers

PMID38184696
PMCPMC10771536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.